Neutralization of IL-9 ameliorates post-stroke damage to the blood-brain barrier (BBB) via down-regulating astrocyte-derived VEGF-A, which suggested VEGFA as a novel therapeutic target of immune intervention of IS (Tan et al., 2019). Here, IL9 is linked to stroke disorder.